摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-cyano-10-methoxy-7H-pyrido<3,2-c>carbazole | 109960-21-6

中文名称
——
中文别名
——
英文名称
6-cyano-10-methoxy-7H-pyrido<3,2-c>carbazole
英文别名
10-methoxy-7H-pyrido[3,2-c]carbazole-6-carbonitrile
6-cyano-10-methoxy-7H-pyrido<3,2-c>carbazole化学式
CAS
109960-21-6
化学式
C17H11N3O
mdl
——
分子量
273.294
InChiKey
JMPNGBVADBFNMN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    61.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    (Z)-2-(5-methoxy-1H-indol-2-yl)-3-pyridin-3-ylprop-2-enenitrile 以31%的产率得到
    参考文献:
    名称:
    LEON, P.;GARBAY-JAUREGUIBERRY, C.;BARSI, M. C.;LE, PECQ J. B.;ROQUES, B. +, J. MED. CHEM., 30,(1987) N 11, 2074-2080
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Modulation of the antitumor activity by methyl substitutions in the series of 7H-pyridocarbazole monomers and dimers
    作者:P. Leon、C. Garbay-Jaureguiberry、M. C. Barsi、J. B. Le Pecq、Bernard P. Roques
    DOI:10.1021/jm00394a024
    日期:1987.11
    The structure of the dimeric antitumor drug ditercalinium (NSC 366241) [2,2'-([4,4'-bipiperidine]-1,1'-diyldi-2,1-ethanediyl)bis[10 -methoxy-7H-pyrido[4,3-c]carbazolium] tetramethanesulfonate] was modified by introduction of methyl groups in various positions of the aromatic ring. Monomeric analogues with the nitrogen atom of the pyridinic ring in different positions have also been synthesized. Pharmacological properties and DNA interactions of the new compounds are reported. In contrast with the monomeric analogue of ditercalinium, which was inactive, methyl substitutions on the 10-methoxy-7H-pyrido[4,3-c]carbazolium in positions 6 or 7 led to monomers endowed with small but significant activity. As expected, dimerization of the methyl-substituted pyridocarbazoles yielded DNA bisintercalators with affinity slightly higher than that of the unsubstituted parent compounds. These dimers, characterized by a relatively better therapeutic index, have the same mechanism of action as ditercalinium. Otherwise, in monomeric and dimeric series, methyl substitution in position 4 or 5 provided inactive compounds unable to intercalate into DNA. All these results are in agreement with the previously proposed geometry for the complex of ditercalinium with DNA.
查看更多